Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,643 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx

NCT00071890

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • Hospital Henri Mondor Créteil, France
View Trial Details
Completed

A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy

NCT00053638

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 58 locations
View Trial Details
Completed

A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)

NCT00094367

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • GSK Investigational Site Montgomery, Alabama, United States
  • GSK Investigational Site Glendale, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 178 locations
View Trial Details
Completed

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

NCT00028301

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Cooper Green Hosp Birmingham, Alabama, United States
  • Phoenix Body Positive Phoenix, Arizona, United States
  • East Bay AIDS Ctr Berkeley, California, United States
  • Saint Francis Mem Hosp / HIV Care Unit San Francisco, California, United States
View all 97 locations
View Trial Details
Completed

A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials

NCT00029913

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +15 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Mt Zion Hospital San Francisco, California, United States
  • San Francisco Dept of Hlth / AIDS Office San Francisco, California, United States
  • University of MD - Inst. of Human Virology (IHV) Baltimore, Maryland, United States
View all 21 locations
View Trial Details

Related conditions